Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) Interest Expenses (2016 - 2025)

Historic Interest Expenses for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $1.5 million.

  • AtriCure's Interest Expenses fell 1193.76% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 1375.48%. This contributed to the annual value of $6.4 million for FY2024, which is 748.01% down from last year.
  • As of Q3 2025, AtriCure's Interest Expenses stood at $1.5 million, which was down 1193.76% from $1.5 million recorded in Q2 2025.
  • Over the past 5 years, AtriCure's Interest Expenses peaked at $1.8 million during Q4 2023, and registered a low of $1.0 million during Q1 2022.
  • In the last 5 years, AtriCure's Interest Expenses had a median value of $1.5 million in 2025 and averaged $1.5 million.
  • As far as peak fluctuations go, AtriCure's Interest Expenses surged by 6360.0% in 2023, and later crashed by 1929.92% in 2024.
  • AtriCure's Interest Expenses (Quarter) stood at $1.1 million in 2021, then surged by 44.14% to $1.6 million in 2022, then increased by 15.18% to $1.8 million in 2023, then dropped by 19.3% to $1.5 million in 2024, then rose by 1.17% to $1.5 million in 2025.
  • Its Interest Expenses was $1.5 million in Q3 2025, compared to $1.5 million in Q2 2025 and $1.4 million in Q1 2025.